Latest Period
Q2 2026
Security Snapshot
Astrana Health, Inc. - Common Stock (ASTH) Institutional Ownership
CUSIP: 03763A207
13F Institutional Holders and Ownership History from Q4 2017 to Q2 2026
Institutions Reporting
207
Shares (Excl. Options)
32,123,424
Price
$46.41
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ASTH on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 32,123,424
- Total 13F value
- $1,489,347,761
- Portfolio coverage rank
- 0%
- Share change
- +2,123,944
- Value change
- +$104,542,594
- Number of holders
- 207
- Shares outstanding
- 49,605,599
- SEC-reported price per share
- $35.83
- Insider filing price
- $35.83
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ASTH - Astrana Health, Inc. - Common Stock is tracked under CUSIP 03763A207.
- 207 institutions reported positions in Q2 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 170 to 207 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $733,415,048 to $1,489,347,761.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 207 institutions filings for Q2 2026.
Security key
03763A207
Latest holder period
Q2 2026
13F holders
207
13D/G owners
3
CIK / CUSIP context first
Open Q2 2026 holders
ASTH full holder history
Astrana Health, Inc. SEC filings
Astrana Health, Inc. company facts
Astrana Health, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03763A207:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
ASTH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 12% | +9.1% | $191,646,870 | -$6,109,882 | 6,234,446 | -3.1% | BlackRock, Inc. | 31 Mar 2025 |
| ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | 11% | -10% | $188,522,333 | -$21,514,803 | 6,132,802 | -10% | Allied Physicians of California, a Professional Medical Corporation | 15 Feb 2025 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3% | $126,195,454 | 2,648,939 | Vanguard Portfolio Management | 30 Jun 2026 |
As of 30 Jun 2026, 207 institutional investors reported holding 32,123,424 shares of Astrana Health, Inc. - Common Stock (ASTH). This represents 65% of the company’s total 49,605,599 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
53%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14% | 6,899,990 | +12% | 0% | $320,228,534 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.3% | 2,605,775 | +14% | 0.01% | $120,934,018 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.9% | 1,946,431 | +14% | 0% | $90,333,863 |
| STATE STREET CORP | 3.5% | 1,738,930 | +5.4% | 0% | $80,703,741 |
| 325 CAPITAL LLC | 3.3% | 1,613,843 | -12% | 18% | $74,898,454 |
| DIMENSIONAL FUND ADVISORS LP | 3% | 1,468,508 | +7.3% | 0.01% | $68,147,789 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.6% | 1,292,573 | -3.7% | 0.01% | $59,988,313 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 1,167,974 | +13% | 0% | $54,215,672 |
| BANK OF AMERICA CORP /DE/ | 1.7% | 852,145 | +48% | 0% | $39,548,050 |
| FMR LLC | 1.4% | 685,922 | +65% | 0% | $31,833,629 |
| WELLS FARGO & COMPANY/MN | 1.3% | 664,940 | +546% | 0.01% | $30,859,865 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.3% | 652,669 | +1.3% | 0% | $30,290,368 |
| AMERIPRISE FINANCIAL INC | 1% | 512,110 | -7.2% | 0% | $23,767,026 |
| NORTHERN TRUST CORP | 1% | 505,044 | +15% | 0% | $23,439,092 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | 0.96% | 475,941 | -13% | 0.18% | $22,088,422 |
| ROYCE & ASSOCIATES LP | 0.95% | 472,480 | +19% | 0.18% | $21,927,797 |
| SteelPeak Wealth, LLC | 0.94% | 464,937 | -17% | 0.57% | $21,577,727 |
| MORGAN STANLEY | 0.87% | 433,508 | +28% | 0% | $20,119,143 |
| Invesco Ltd. | 0.77% | 381,830 | +8.7% | 0% | $17,720,731 |
| VANGUARD FIDUCIARY TRUST CO | 0.62% | 307,022 | +4.8% | 0% | $14,248,891 |
| GOLDMAN SACHS GROUP INC | 0.55% | 271,798 | -8% | 0% | $12,614,145 |
| PRINCIPAL FINANCIAL GROUP INC | 0.54% | 267,706 | +0.66% | 0.01% | $12,424,235 |
| EARNEST PARTNERS LLC | 0.52% | 258,991 | +18% | 0.04% | $12,019,772 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 0.5% | 249,410 | -48% | 0.03% | $11,575,118 |
| Bank of New York Mellon Corp | 0.47% | 234,896 | +5.9% | 0% | $10,901,538 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
35
Latest
Q2 2026
Rows shown
1-25 of 35
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 32,123,424 | $1,489,347,761 | +$104,542,594 | $46.41 | 207 |
| 2026 Q1 | 29,910,654 | $733,415,048 | +$14,458,237 | $24.52 | 170 |
| 2025 Q4 | 29,137,341 | $724,380,671 | +$62,743,872 | $24.81 | 174 |
| 2025 Q3 | 26,741,841 | $759,043,836 | +$22,746,916 | $28.35 | 186 |
| 2025 Q2 | 25,772,189 | $641,392,329 | -$15,342,979 | $24.88 | 161 |
| 2025 Q1 | 26,257,633 | $814,637,036 | +$5,862,823 | $31.01 | 168 |
| 2024 Q4 | 26,057,927 | $822,017,819 | +$3,128,832 | $31.53 | 177 |
| 2024 Q3 | 25,295,709 | $1,465,673,353 | +$131,700,353 | $57.94 | 186 |
| 2024 Q2 | 23,072,576 | $935,815,210 | +$22,763,995 | $40.56 | 169 |
| 2024 Q1 | 22,756,494 | $955,393,465 | +$24,413,741 | $41.99 | 158 |
| 2023 Q4 | 22,178,838 | $849,210,903 | +$26,256,665 | $38.30 | 141 |
| 2023 Q3 | 21,503,159 | $663,623,547 | +$22,662,738 | $30.85 | 132 |
| 2023 Q2 | 20,757,071 | $656,229,537 | +$22,212,849 | $31.60 | 129 |
| 2023 Q1 | 20,034,782 | $730,631,066 | +$14,461,853 | $36.47 | 131 |
| 2022 Q4 | 19,704,382 | $583,144,207 | -$13,404,604 | $29.59 | 129 |
| 2022 Q3 | 19,814,272 | $772,607,625 | +$70,014,740 | $39.00 | 148 |
| 2022 Q2 | 17,767,757 | $685,808,256 | +$18,274,263 | $38.59 | 126 |
| 2022 Q1 | 17,609,470 | $853,298,644 | +$10,418,988 | $48.47 | 129 |
| 2021 Q4 | 17,108,614 | $1,256,730,970 | +$26,349,379 | $73.48 | 140 |
| 2021 Q3 | 16,644,270 | $1,516,521,911 | +$595,571,146 | $91.05 | 137 |
| 2021 Q2 | 10,256,705 | $644,299,364 | +$260,959,544 | $62.81 | 102 |
| 2021 Q1 | 6,359,542 | $172,275,211 | +$32,027,527 | $27.09 | 75 |
| 2020 Q4 | 5,211,206 | $95,222,607 | +$2,906,278 | $18.27 | 60 |
| 2020 Q3 | 5,058,422 | $90,682,749 | +$15,496,005 | $17.94 | 62 |
| 2020 Q2 | 4,195,952 | $69,229,389 | +$12,105,432 | $16.50 | 49 |